antibodies

Hepatitis B virus is shown in orange against a blue background.
| 6 min read
An illustration of the creation of a hybridoma cell line for producing monoclonal antibodies, showing the fusion of a myeloma cell with an antibody-producing B cell and the subsequent selection of desired hybridomas using a fluorescently tagged antigen.
| 3 min read
Amir Razai wears a white lab coat while holding a column in a laboratory at Arialys Therapeutics.
| 7 min read
An illustration of a T cell targeting a cancer cell
| 2 min read
3D illustration of a DNA double helix structure with a pixelated visual effect
Available on Demand
A drawing of a purple hand with 4 pills in the open palm. One pill contains a syringe. In the background are DNA, antibodies, a cross-sectional diagram of a robotic capsule, and mathematic equations.
| 10+ min read
An image of a peanut against a blue background symbolic of breakthroughs in gene therapy for peanut allergies.
| 9 min read
A 3D illustration of an antibody protein composed of multiple chains, each represented in distinct colors.
Available on Demand
Blue and purple rod-shaped bacteria line the walls of the intestines, which are colored grey.
| 5 min read
A dog biting the words A Deadly Bite is drawn over a green background, and orange colored rabies viruses are pictured next to the dog.
| 10+ min read
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a single cell surrounded by small molecular particles in a red biological environment.
Measuring mRNA and protein together at single cell resolution can uncover tumor-specific signaling activity and immune features.
Illustration of an antibody intertwined with a DNA double helix.
Discover how CRISPR and single-cell RNA sequencing can connect disease-associated variants to regulatory elements, genes, and pathways.
Digital illustration of the human digestive system highlighting the liver, stomach, and intestines.
Explore how human gut-liver models can improve the translation of preclinical findings into clinical pharmacokinetic predictions.